Financhill
Back

Insight Molecular Diagnostics Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

IMDX
Insight Molecular Diagnostics

Last Price:
$2.94
Seasonality Move:
-2.21%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Insight Molecular Diagnostics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.89 Sell
20-day SMA: 3.13 Sell
50-day SMA: 3.02 Sell
200-day SMA: 2.82 Buy
8-day EMA: 2.36 Buy
20-day EMA: 1.44 Buy
50-day EMA: 0.7 Buy
200-day EMA: 0.19 Buy

Insight Molecular Diagnostics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 44.42 Sell
Chaikin Money Flow: 9980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.7 - 3.4) Sell
Bollinger Bands (100): (2.72 - 3.44) Sell

Insight Molecular Diagnostics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Insight Molecular Diagnostics Stock

Is Insight Molecular Diagnostics Stock a Buy?

IMDX Technical Analysis vs Fundamental Analysis

Sell
30
Insight Molecular Diagnostics (IMDX) is a Sell

Is Insight Molecular Diagnostics a Buy or a Sell?

Insight Molecular Diagnostics Stock Info

Market Cap:
80.9M
Price in USD:
2.83
Share Volume:
20K

Insight Molecular Diagnostics 52-Week Range

52-Week High:
4.75
52-Week Low:
1.92
Sell
30
Insight Molecular Diagnostics (IMDX) is a Sell

Insight Molecular Diagnostics Share Price Forecast

Is Insight Molecular Diagnostics Stock a Buy?

Fundamental Analysis of Insight Molecular Diagnostics

Is Insight Molecular Diagnostics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.03 per share.

Technical Analysis of Insight Molecular Diagnostics

Should I short Insight Molecular Diagnostics stock?

* Insight Molecular Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.